Thursday, September 23, 2021 12:56:13 PM
Wallach: Based on this most current information, it is anticipated that shipments will commence before the end of August. We will, regardless of the cost, fly in the first round of inventory as previously committed to. As the largest Capstone shareholder, I'm acutely sensitive to the frustrations that investors are all experiencing with the delay of the product launch. Rest assured, your management has never lost sight of its goals and have taken proactive steps to maximize the program potential for the balance of 2021.
In addition to the testing timelines, supply chains have been impacted and logistics, costs, and space availability have presented challenges as well. To help mitigate the supply chain bottlenecks going forward, we have placed component order as well in advance, which will enable us to produce an estimated 3,000 mirrors in Q3. Depending on the customer demand in the weeks ahead, we are prepared to further commit to long lead time components for an additional 2,000 mirrors for Q4 production.
Frankly, there is no playbook for the adversity we have faced as a company during the pandemic. Many companies have simply closed their doors as they face defeat in these difficult times. I think is important for all of us to recognize that the Company has not only survived this global crisis, but is on the verge of launching its most impressive innovation in the Company's history. The fact that we are soon to enter the smart home market with our Capstone Connected Smart mirrors is at the very least commendable.
We are well-positioned to take our place in the 21st century technology arena and look forward to focusing our energies and growing the Company's revenues and increasing shareholder value. Keep in mind the market we are entering is explosive. The management remains optimistic and enthusiastic because the program potential is clear.
Recent CAPC News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 04:55:51 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 07:14:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/03/2023 06:12:39 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM